docosahexaenoyl lysophosphatidylcholine

Also Known As:

hydroperoxydocosahexaenoyl-lysoPC; lysoPC DHA; lysophosphatidylcholine docohexaenoate; sn-2-docosahexaenoyl lysophosphatidylcholine; sn-2-lysophosphatidylcholine docohexaenoic acid ester

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Bernoud-Hubac, Nathalie: 1 article (01/2016)
2.	Breton, Gildas: 1 article (01/2016)
3.	Da Silva, Pedro: 1 article (01/2016)
4.	Fenart, Laurence: 1 article (01/2016)
5.	Foumaux, Baptiste: 1 article (01/2016)
6.	Gosselet, Fabien: 1 article (01/2016)
7.	Géloën, Alain: 1 article (01/2016)
8.	Hachem, Mayssa: 1 article (01/2016)
9.	Lagarde, Michel: 1 article (01/2016)
10.	Picq, Madeleine: 1 article (01/2016)

Related Diseases

1.	Ischemic Stroke 01/01/2016 - "We used a structured phosphatidylcholine to mimic 2-docosahexaenoyl-lysoPC (lysoPC-DHA), named AceDoPC (1-acetyl,2-docosahexaenoyl-glycerophosphocholine), that may be considered as a stabilized form of the physiological lysoPC-DHA and that is neuroprotective in experimental ischemic stroke. "

Related Drugs and Biologics

1.	Phosphatidylcholines (Phosphatidylcholine)
2.	1- acetyl- 2- docosahexaenoyl- glycerophosphocholine